Isamu Tachibana

5PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 04, 2026
Biomarker-guided selection of intravesical therapy in high-risk non-muscle invasive bladder cancer: A contemporary review.

|Jan 25, 2025
A Review of Neoadjuvant Therapy for Localized and Locally Advanced Renal Cell Carcinoma.

Qian Qin, Isamu Tachibana, Vitaly Margulis

|Sep 01, 2023
Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual Cancer.

Luca Antonelli, Davide Ardizzone, Isamu Tachibana

|Feb 02, 2023
Primary Retroperitoneal Lymph Node Dissection for Stage II Seminoma: Is Surgery the New Path Forward?

Isamu Tachibana, Andre Alabd, Yan Tong

|Jun 08, 2022
Primary Retroperitoneal Lymph Node Dissection for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumor-N1, N2, and N3 Disease: Is Adjuvant Chemotherapy Necessary?

Isamu Tachibana, Sean Q Kern, Antoin Douglawi

Pageof 1

Frequent Collaborators

3 joint publications

Nabil Adra

3 joint publications

Clint Cary

1 joint publications

Antoin Douglawi

1 joint publications

Yan Tong